Jerman Michael Allen bought INTI
May 4, 2026 · Form 4 insider transaction
Jerman Michael Allen bought 50,000 shares of Inhibitor Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 51 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$0.00
Total value
N/A
InsiderJerman Michael Allen
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 4, 2026
Filing dateJune 24, 2026
Shares owned after180,411
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2025 Equity Incentive Plan.